CoChat

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

Open access
Junker, A. E., Gluud, L., Holst, J. J., Knop, F. K., Vilsbøll, T. · 2016 · Journal of Internal Medicine
Cited by 88

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Objective: We evaluated whether patients with histologically verified nonalcoholic fatty liver disease ( NAFLD ) have an impaired incretin effect and hyperglucagonaemia. Methods: Four groups matched for age, sex and body mass index were studied: (i) 10 patients with normal glucose tolerance and NAFLD ; (ii) 10 patients with type 2 diabetes and NAFLD ; (iii) eight patients with type 2 diabetes and no liver disease; and (iv) 10 controls. All participants underwent a 50‐g oral glucose tolerance test ( OGTT ) and an isoglycaemic intravenous glucose infusion ( IIGI ). We determined the incretin effect by relating the beta cell secretory responses during the OGTT and IIGI . Data are presented as medians (interquartile range), and the groups were compared by using the Kruskal–Wallis test. Results: Controls exhibited a higher incretin effect [55% (43–73%)] compared with the remaining three groups ( P < 0.001): 39% (44–71%) in the nondiabetic NAFLD patients, 20% (−5−50%) in NAFLD patients with type 2 diabetes, and 2% (−8−6%) in patients with type 2 diabetes and no liver disease. We found fasting hyperglucagonaemia in NAFLD patients with [7.5 pmol L −1 (6.8–15 pmol L −1 )] and without diabetes [7.5 pmol L −1 (5.0–8.0 pmol L −1 )]. Fasting glucagon levels were lower but similar in patients with type 2 diabetes and no liver disease [4.5 pmol L −1 (3.0–6.0 pmol L −1 )] and controls [3.4 pmol L −1 (1.8–6.0 pmol L −1 )]. All groups had similar glucagon‐like peptide‐1 and glucose‐dependent insulinotropic polypeptide responses. Conclusions: Patients with NAFLD have a reduced incretin effect and fasting hyperglucagonaemia, with the latter occurring independently of glucose (in)tolerance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.12462

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. 10.1111/j.1365-2036.2007.03246.x · DOI · Paper page
  2. 10.1097/MOT.0b013e3283615d30 · DOI
  3. 10.1053/jhep.2003.50193 · DOI · Paper page
  4. 10.1038/nrgastro.2013.182 · DOI · Paper page
  5. 10.2337/dc06-2247 · DOI · Paper page
  6. Kalra S, 2013, Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in india (SPRINT), J Assoc Physicians India, 61, 448
  7. 10.1002/hep.27098 · DOI
  8. 10.1152/physrev.00034.2006 · DOI · Paper page
  9. 10.2337/dc11-s227 · DOI · Paper page
  10. 10.1111/j.1463-1326.2011.01549.x · DOI · Paper page
  11. 10.1371/journal.pone.0087488 · DOI · Paper page
  12. 10.1152/ajpendo.00700.2009 · DOI · Paper page
  13. 10.1152/ajpendo.00529.2004 · DOI · Paper page
  14. 10.1111/jgh.12981 · DOI
  15. 10.1002/hep.20701 · DOI · Paper page
  16. 10.1007/s00125-006-0566-z · DOI · Paper page
  17. Bablok W, 1988, A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III, J Clin Chem Clin Biochem, 26, 783
  18. 10.1172/JCI115012 · DOI · Paper page
  19. 10.2337/diab.43.4.535 · DOI · Paper page
  20. 10.1016/0167-0115(84)90005-3 · DOI
  21. Miceli JN, 1979, Simultaneous measurements of acetaminophen and salicylate in plasma by liquid chromatography, Clin Chem, 25, 1002, 10.1093/clinchem/25.6.1002 · DOI · Paper page
  22. 10.2337/diacare.22.9.1462 · DOI · Paper page
  23. 10.1002/hep.26988 · DOI · Paper page
  24. 10.1002/hep.25539 · DOI · Paper page
  25. 10.1210/jc.2010-0119 · DOI · Paper page
  26. 10.1002/hep.20734 · DOI · Paper page
  27. 10.1016/j.regpep.2013.08.002 · DOI
  28. 10.1152/ajpendo.00571.2005 · DOI · Paper page
  29. 10.1007/s00125-007-0598-z · DOI
  30. Shah P, 1999, Impact of lack of suppression of glucagon on glucose tolerance in humans, Am J Physiol, 277, E283
  31. 10.1016/j.metabol.2005.03.024 · DOI
  32. 10.1007/s00125-009-1443-3 · DOI · Paper page
  33. 10.1055/s-2004-821225 · DOI · Paper page
  34. 10.2337/diabetes.53.2.410 · DOI · Paper page
  35. 10.1073/pnas.0237106100 · DOI · Paper page
  36. 10.2337/db11-1605 · DOI · Paper page
  37. 10.1152/ajpendo.00125.2003 · DOI · Paper page

Cited by

See all 88

Metadata

Authors
Junker, A. E., Gluud, L., Holst, J. J., Knop, F. K., & Vilsbøll, T.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2016-01-05
Volume
279
Issue
5
Pages
485-493
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2223377380
Cited by
88
References
14
FWCI
8.18
Type
journal article
Language
en
Open access
bronze
Funders
Novo Nordisk

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.